ftInvstr
METROPOLIS · Healthcare ₹584.5 +1.32% Mkt Cap ₹12096 Cr overvalued

METROPOLIS

Healthcare Diagnostics & Research
₹584.5
+1.32% today · 30d +11.33%
as of 2026-11-09
Price · Daily Candles
AI narrative is temporarily unavailable for METROPOLIS. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2026-09-30
REVENUE
₹497 Cr
+15.76% YoY
NET PROFIT
₹75 Cr
+42.72% YoY
OPM
28.2%
+2.83pp YoY
EPS
₹3.64
PE 53.45
Intrinsic value · DCF ₹73.20 · Margin of safety -87.5% (overvalued) · FCF yield 2.54%
◇ Sector Position
PEERPEROCE %
METROPOLIS53.4518.0
SAILIFE103.8124.25
LALPATHLAB57.3731.74
SYNGENE94.416.59
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
66
SCORE / 100
Overall
6-axis composite of the sections below.
Performance STRONG 75
Valuation STRETCHED 20
Growth STRONG 78
Profitability HIGH 85
Technicals NEUTRAL 58
Risk LOW 80
Key Stats
TTM PE
53.45
P/B
7.26
52W HIGH
₹609.05
OFF HIGH
-4.03%
DIV YIELD
0.52%
MKT CAP
₹12096 Cr
◉ Active Signals
MACDBullish5.7313
RSI(14)Bullish61.49
Near 52W HighBullish-4.03
Street Consensus
19 analysts
₹683.0
mean target
Low ₹550.0Now ₹584.5High ₹886.0
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold METROPOLIS and at what entry.

Sign up freeSign in